跳转至内容
Merck
CN

R103

Sigma-Aldrich

利坦丝林

powder

别名:

6-[2- [4-(双(4-氟苯基)亚甲基] -1-哌啶基]乙基] -7-甲基-5H-噻唑并[3,2-a]嘧啶-5-酮

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C27H25F2N3OS
CAS号:
分子量:
477.57
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

形式

powder

颜色

white

溶解性

methanol: >10 mg/mL
DMSO: >10.1 mg/mL
2-hydroxypropyl-β-cyclodextrin: insoluble
H2O: insoluble
dilute aqueous base: insoluble

SMILES字符串

CC1=C(CCN2CCC(\CC2)=C(\c3ccc(F)cc3)c4ccc(F)cc4)C(=O)N5C=CSC5=N1

InChI

1S/C27H25F2N3OS/c1-18-24(26(33)32-16-17-34-27(32)30-18)12-15-31-13-10-21(11-14-31)25(19-2-6-22(28)7-3-19)20-4-8-23(29)9-5-20/h2-9,16-17H,10-15H2,1H3

InChI key

JUQLTPCYUFPYKE-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

应用

利坦色林已用于行为测试,并用作 5-羟色胺 2A 受体(5-HT2A)受体拮抗剂。

生化/生理作用

利坦色林是有效的 5-羟色胺 2A 受体(5-HT2A)羟色胺受体拮抗剂/反向激动剂,可穿过血脑屏障。它调节 5-HT 2A 受体,并被认为具有抗帕金森作用。利坦色林还通过调节情绪、认知和消极症状来影响精神分裂症。
有效的 5-HT2A 5-羟色胺受体拮抗剂/反向激动剂,可穿越血脑屏障。

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone
Hashimoto H, et al.
Journal of Neurochemistry, 110(2), 595-602 (2009)
Anna Sławińska et al.
Neuropharmacology, 66, 225-235 (2012-05-29)
Previous studies demonstrated that the Group III mGlu receptor-selective orthosteric agonist, LSP1-2111 produced anxiolytic- but not antidepressant-like effects upon peripheral administration. Herein, we report the pharmacological actions of Lu AF21934, a novel, selective, and brain-penetrant positive allosteric modulator (PAM) of
K Stachowicz et al.
Neuropharmacology, 57(3), 227-234 (2009-06-23)
Our earlier studies have demonstrated that (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid ACPT-I, a group III mGlu receptor agonist, produced anxiolytic-like and antidepressant-like actions after central administration. Here we describe the anxiolytic-like effects of ACPT-I after intraperitoneal administration in the stress-induced hyperthermia (SIH), elevated
Marcus C Ferguson et al.
Neuropharmacology, 59(1-2), 31-36 (2010-04-07)
Clinical observations have suggested that ritanserin, a 5-HT(2A/C) receptor antagonist may reduce motor deficits in persons with Parkinson's Disease (PD). To better understand the potential antiparkinsonian actions of ritanserin, we compared the effects of ritanserin with the selective 5-HT(2A) receptor
Modulation by 5-HT2A receptors of aggressive behavior in isolated mice
Sakaue M, et al.
Japanese Journal of Pharmacology, 89(1), 89-92 (2002)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门